Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Commentary

Non-oxidative vs Oxidative Forms of Modified Low-density Lipoprotein: What is More Important in Atherogenesis?

Author(s): Alexander Orekhov*, Victoria Khotina, Vasily Sukhorukov and Igor Sobenin

Volume 31, Issue 17, 2024

Published on: 10 January, 2024

Page: [2309 - 2313] Pages: 5

DOI: 10.2174/0109298673294245240102105814

open access plus

conference banner
Next »
[1]
Zhao, Y.; Xu, Q.; He, N.; Jiang, M.; Chen, Y.; Ren, Z.; Tang, Z.; Wu, C.; Liu, L. Non-oxidative modified low-density lipoproteins: The underappreciated risk factors for atherosclerosis. Curr. Med. Chem., 2023, 31.
[http://dx.doi.org/10.2174/0929867331666230807154019] [PMID: 37550912]
[2]
Austin, M.; Krauss, R. Genetic control of low-density-lipoprotein subclasses. Lancet, 1986, 328(8507), 592-595.
[http://dx.doi.org/10.1016/S0140-6736(86)92425-6] [PMID: 2875318]
[3]
Avogaro, P.; Bon, G.B.; Cazzolato, G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis, 1988, 8(1), 79-87.
[http://dx.doi.org/10.1161/01.ATV.8.1.79] [PMID: 3341993]
[4]
Orekhov, A.N.; Tertov, V.V.; Mukhin, D.N.; Mikhailenko, I.A. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem. Biophys. Res. Commun., 1989, 162(1), 206-211.
[http://dx.doi.org/10.1016/0006-291X(89)91982-7] [PMID: 2751649]
[5]
Austin, M.A.; Breslow, J.L.; Hennekens, C.H.; Buring, J.E.; Willett, W.C.; Krauss, R.M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA, 1988, 260(13), 1917-1921.
[http://dx.doi.org/10.1001/jama.1988.03410130125037] [PMID: 3418853]
[6]
Krauss, R.M. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr. Opin. Lipidol., 1994, 5(5), 339-349.
[http://dx.doi.org/10.1097/00041433-199410000-00005] [PMID: 7858908]
[7]
Krauss, R.M. Dense low density lipoproteins and coronary artery disease. Am. J. Cardiol., 1995, 75(6), 53B-57B.
[http://dx.doi.org/10.1016/0002-9149(95)80012-H] [PMID: 7863975]
[8]
Krauss, R.M. Atherogenicity of triglyceride-rich lipoproteins. Am. J. Cardiol., 1998, 81(4), 13B-17B.
[http://dx.doi.org/10.1016/S0002-9149(98)00032-0] [PMID: 9526808]
[9]
Cazzolato, G.; Avogaro, P.; Bittolo-Bon, G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic. Biol. Med., 1991, 11(3), 247-253.
[http://dx.doi.org/10.1016/0891-5849(91)90120-R] [PMID: 1937142]
[10]
Avogaro, P.; Cazzolato, G.; Bittolo-Bon, G. Some questions concerning a small, more electronegative LDL circulating in human plasma. Atherosclerosis, 1991, 91(1-2), 163-171.
[http://dx.doi.org/10.1016/0021-9150(91)90198-C] [PMID: 1811552]
[11]
Bittolo-Bon, G.; Cazzolato, G. Analytical capillary isotachophoresis of total plasma lipoproteins: a new tool to identify atherogenic low density lipoproteins. J. Lipid Res., 1999, 40(1), 170-177.
[http://dx.doi.org/10.1016/S0022-2275(20)33353-8] [PMID: 9869664]
[12]
Akyol, S.; Lu, J.; Akyol, O.; Akcay, F.; Armutcu, F.; Ke, L.Y.; Chen, C.H. The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications. Trends Cardiovasc. Med., 2017, 27(4), 239-246.
[http://dx.doi.org/10.1016/j.tcm.2016.11.002] [PMID: 28040327]
[13]
Ke, L.Y.; Law, S.H.; Mishra, V.K.; Parveen, F.; Chan, H.C.; Lu, Y.H.; Chu, C.S. Molecular and cellular mechanisms of electronegative lipoproteins in cardiovascular diseases. Biomedicines, 2020, 8(12), 550.
[http://dx.doi.org/10.3390/biomedicines8120550] [PMID: 33260304]
[14]
Benitez, S.; Puig, N.; Rives, J.; Solé, A.; Sánchez-Quesada, J.L. Can electronegative LDL act as a multienzymatic complex? Int. J. Mol. Sci., 2023, 24(8), 7074.
[http://dx.doi.org/10.3390/ijms24087074] [PMID: 37108253]
[15]
Orekhov, A.N.; Ivanova, E.A.; Bobryshev, Y.V. Naturally occurring multiple-modified low density lipoprotein. In: Blood Lipids and Lipoproteins; Ruiz, M., Ed.; , 2015; pp. 13-54.
[16]
Tertov, V.V.; Bittolo-Bon, G.; Sobenin, I.A.; Cazzolato, G.; Orekhov, A.N.; Avogaro, P. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions. Exp. Mol. Pathol., 1995, 62(3), 166-172.
[http://dx.doi.org/10.1006/exmp.1995.1018] [PMID: 8612720]
[17]
Tertov, V.V.; Sobenin, I.A.; Gabbasov, Z.A.; Popov, E.G.; Jaakkola, O.; Solakivi, T.; Nikkari, T.; Smirnov, V.N.; Orekhov, A.N. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab. Invest., 1992, 67(5), 665-675.
[PMID: 1434544]
[18]
La Belle, M.; Krauss, R.M. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J. Lipid Res., 1990, 31(9), 1577-1588.
[http://dx.doi.org/10.1016/S0022-2275(20)42342-9] [PMID: 2246611]
[19]
Tertov, V.V.; Kaplun, V.V.; Sobenin, I.A.; Orekhov, A.N. Low-density lipoprotein modification occurring in human plasma. Atherosclerosis, 1998, 138(1), 183-195.
[http://dx.doi.org/10.1016/S0021-9150(98)00023-9] [PMID: 9678784]
[20]
Palinski, W.; Rosenfeld, M.E.; Ylä-Herttuala, S.; Gurtner, G.C.; Socher, S.S.; Butler, S.W.; Parthasarathy, S.; Carew, T.E.; Steinberg, D.; Witztum, J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci., 1989, 86(4), 1372-1376.
[http://dx.doi.org/10.1073/pnas.86.4.1372] [PMID: 2465552]
[21]
Orekhov, A.N.; Tertov, V.V.; Kabakov, A.E. Adamova IYu; Pokrovsky, S.N.; Smirnov, V.N. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler. Thromb., 1991, 11(2), 316-326.
[http://dx.doi.org/10.1161/01.ATV.11.2.316] [PMID: 1998649]
[22]
Itabe, H.; Obama, T. The oxidized lipoproteins in vivo: Its diversity and behavior in the human circulation. Int. J. Mol. Sci., 2023, 24(6), 5747.
[http://dx.doi.org/10.3390/ijms24065747] [PMID: 36982815]
[23]
Orekhov, A.N.; Sukhorukov, V.N.; Nikiforov, N.G.; Kubekina, M.V.; Sobenin, I.A.; Foxx, K.K.; Pintus, S.; Stegmaier, P.; Stelmashenko, D.; Kel, A.; Poznyak, A.V.; Wu, W.K.; Kasianov, A.S.; Makeev, V.Y.; Manabe, I.; Oishi, Y. Signaling pathways potentially responsible for foam cell formation: Cholesterol accumulation or inflammatory response—what is first? Int. J. Mol. Sci., 2020, 21(8), 2716.
[http://dx.doi.org/10.3390/ijms21082716] [PMID: 32295185]
[24]
Steinberg, D. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis? Curr. Opin. Lipidol., 2000, 11(6), 603-607.
[http://dx.doi.org/10.1097/00041433-200012000-00006] [PMID: 11086333]
[25]
Kris-Etherton, P.M.; Lichtenstein, A.H.; Howard, B.V.; Steinberg, D.; Witztum, J.L. Antioxidant vitamin supplements and cardiovascular disease. Circulation, 2004, 110(5), 637-641.
[http://dx.doi.org/10.1161/01.CIR.0000137822.39831.F1] [PMID: 15289389]

Rights & Permissions Print Cite
Article Metrics
27
3
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy